BioMarin Pharmaceutical, Inc. (BMRN)
55.95
-0.68
(-1.20%)
USD |
NASDAQ |
Oct 23, 16:00
55.96
+0.01
(+0.02%)
After-Hours: 20:00
BioMarin Pharmaceutical Price to Book Value : 1.713 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.713 |
| October 22, 2026 | 1.734 |
| October 21, 2026 | 1.690 |
| October 20, 2026 | 1.728 |
| October 19, 2026 | 1.674 |
| October 16, 2026 | 1.674 |
| October 15, 2026 | 1.716 |
| October 14, 2026 | 1.688 |
| October 13, 2026 | 1.665 |
| October 12, 2026 | 1.696 |
| October 09, 2026 | 1.678 |
| October 08, 2026 | 1.680 |
| October 07, 2026 | 1.690 |
| October 06, 2026 | 1.721 |
| October 05, 2026 | 1.762 |
| October 02, 2026 | 1.750 |
| October 01, 2026 | 1.789 |
| September 30, 2026 | 1.837 |
| September 29, 2026 | 1.833 |
| September 28, 2026 | 1.820 |
| September 25, 2026 | 1.845 |
| September 24, 2026 | 1.878 |
| September 23, 2026 | 1.904 |
| September 22, 2026 | 1.94 |
| September 21, 2026 | 1.961 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.958 |
| September 17, 2026 | 1.992 |
| September 16, 2026 | 1.982 |
| September 15, 2026 | 1.973 |
| September 14, 2026 | 2.033 |
| September 11, 2026 | 2.011 |
| September 10, 2026 | 2.006 |
| September 09, 2026 | 1.972 |
| September 08, 2026 | 1.979 |
| September 04, 2026 | 2.037 |
| September 03, 2026 | 2.034 |
| September 02, 2026 | 2.050 |
| September 01, 2026 | 1.985 |
| August 31, 2026 | 1.997 |
| August 28, 2026 | 1.980 |
| August 27, 2026 | 1.999 |
| August 26, 2026 | 2.009 |
| August 25, 2026 | 2.024 |
| August 24, 2026 | 1.992 |
| August 21, 2026 | 2.042 |
| August 20, 2026 | 2.072 |
| August 19, 2026 | 2.122 |
| August 18, 2026 | 2.051 |
| August 17, 2026 | 2.040 |
| August 14, 2026 | 2.062 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascendis Pharma A/S | 9.732 |
| ACADIA Pharmaceuticals, Inc. | 2.599 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Anika Therapeutics, Inc. | 2.088 |
| Cytokinetics, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 150.85 |
| PS Ratio | 3.142 |
| Price to Free Cash Flow | 14.98 |
| Price | 55.95 |
| Earnings Yield | 0.66% |
| Market Cap | 10.83B |
| Operating PE Ratio | 16.98 |
| Normalized PE Ratio | 28.40 |